S'abonner

Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection - 05/05/22

Doi : 10.1016/j.jinf.2021.12.046 
Ying Luo a, , Ying Xue b, , Huijuan Song a, Guoxing Tang a, Wei Liu a, Huan Bai a, Xu Yuan a, Shutao Tong a, , Feng Wang a, , Yimin Cai c, , Ziyong Sun a,
a Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang road 1095, Wuhan 430030, China 
b Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 
c Department of Epidemiology and Biostatistics, Key Laboratory of Environmental Health of Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong road 13, Wuhan, China 

Corresponding authors.

Highlights

Machine learning was firstly evaluated for differentiating ATB from LTBI based on laboratory test data with large cohort including training set, test set, and validation set.
Six models including GBM, MARS, Bagging, GLM, NNET, and FDA were successfully established using machine learning.
GBM model was the promising tool with satisfactory diagnostic performance for discrimination between ATB and LTBI.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

Discriminating active tuberculosis (ATB) from latent tuberculosis infection (LTBI) remains challenging. The present study aims to evaluate the performance of diagnostic models established using machine learning based on routine laboratory indicators in differentiating ATB from LTBI.

Methods

Participants were respectively enrolled at Tongji Hospital (discovery cohort) and Sino-French New City Hospital (validation cohort). Diagnostic models were established based on routine laboratory indicators using machine learning.

Results

A total of 2619 participants (1025 ATB and 1594 LTBI) were enrolled in discovery cohort and another 942 subjects (388 ATB and 554 LTBI) were recruited in validation cohort. ATB patients had significantly higher levels of tuberculosis-specific antigen/phytohemagglutinin ratio and coefficient variation of red blood cell volume distribution width, and lower levels of albumin and lymphocyte count than those of LTBI individuals. Six models were built and the optimal performance was obtained from GBM model. GBM model derived from training set (n = 1965) differentiated ATB from LTBI in the test set (n = 654) with a sensitivity of 84.38% (95% CI, 79.42%-88.31%) and a specificity of 92.71% (95% CI, 89.73%-94.88%). Further validation by an independent cohort confirmed its encouraging value with a sensitivity of 87.63% (95% CI, 83.98%-90.54%) and specificity of 91.34% (95% CI, 88.70%-93.40%), respectively.

Conclusions

We successfully developed a model with promising diagnostic value based on machine learning for the first time. Our study proposed that GBM model may be of great benefit served as a tool for the accurate identification of ATB.

Le texte complet de cet article est disponible en PDF.

Keywords : Machine learning, Diagnostic models, Active tuberculosis, Latent tuberculosis infection, Routine laboratory indicators


Plan


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 84 - N° 5

P. 648-657 - mai 2022 Retour au numéro
Article précédent Article précédent
  • Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case–control and cohort study
  • Tao Lou, Xiaoxing Du, Ping Zhang, Qiucheng Shi, Xinhong Han, Peng Lan, Rushuang Yan, Huangdu Hu, Yanfei Wang, Xueqing Wu, Yan Jiang, Yunsong Yu
| Article suivant Article suivant
  • Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity
  • Leanne Marsay, Christina Dold, Gavin K. Paterson, Yuko Yamaguchi, Jeremy P. Derrick, Hannah Chan, Ian M. Feavers, Martin C.J. Maiden, David Wyllie, Adrian V. Hill, Andrew J. Pollard, Christine S. Rollier

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.